Studies by Yatim and colleagues [112] and Aaes and colleagues [113] showed that RIPK1 and NF-kB signaling can mediate cross-priming of CD8+ T cells and that vaccination with necroptotic cells induces efficient anti-tumor immunity, respectively (the latter the gold standard for immunogenic death). The gene discussed is RIPK1; the disease is neoplasm.